Targeting telomeric DNA damage response as a new strategy to fight immunosenescence and improve vaccine response

The project aims to evaluate the effectiveness of telomeric antisense oligonucleotides in rejuvenating the immune response and enhancing vaccine efficacy in aged mice.

Subsidie
€ 150.000
2023

Projectdetails

Introduction

The immune system is remodeled with age, going through a series of changes known as immunosenescence. These changes include:

  • The involution of primary lymphoid organs
  • The contraction of the immune repertoire
  • A progressive lineage skewing towards the myeloid lineage
  • A low-grade pro-inflammatory status

A consequence of immunosenescence impacting the morbidity and mortality of infectious diseases is a dramatically reduced vaccine response in the elderly. Thus, reducing the burden of immunosenescence has the potential to impact the effectiveness of vaccine response.

Telomere Dysfunction

An established hallmark and driver of age-associated functional decline is telomere dysfunction. Dysfunctional telomeres are actively transcribed to generate telomeric non-coding RNAs (tncRNA), which are essential to recruit DNA Damage Response (DDR) factors at damaged telomeres. This process fuels DDR and causes cellular senescence initiation and maintenance.

Telomeric Antisense Oligonucleotides

Sequence-specific telomeric antisense oligonucleotides (tASOs) target these tncRNAs and effectively inhibit DDR activation, ameliorating age-related phenotypes in mouse models.

Mouse Model

The telomerase-deficient (Terc-/-) mouse model causes telomere shortening and dysfunction, recapitulating features of immunosenescence, including:

  1. Immune system reactivity reduction
  2. Decreased long-term renewal of hematopoietic stem cells
  3. Decreased lymphocyte numbers
  4. Increased neutrophil count

tASOs treatment has a beneficial long-term effect in this model by decreasing immunosenescence and counteracting inflammation.

Future Plans

We now plan to test the efficacy of tASOs treatment on rejuvenating the immune system of aged wild type mice, which represents a physiological setting for aging.

Goals

The final goal will be to assess if tASOs impact vaccine response in both models:

  • Young Terc-/- mice
  • Aged WT mice

In summary, we plan to determine the efficacy of tASOs to improve immune responses, including vaccines, in the elderly.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 150.000
Totale projectbegroting€ 150.000

Tijdlijn

Startdatum1-9-2023
Einddatum28-2-2025
Subsidiejaar2023

Partners & Locaties

Projectpartners

  • IFOM-ISTITUTO FONDAZIONE DI ONCOLOGIA MOLECOLARE ETSpenvoerder

Land(en)

Italy

Vergelijkbare projecten binnen European Research Council

ERC STG

MANUNKIND: Determinants and Dynamics of Collaborative Exploitation

This project aims to develop a game theoretic framework to analyze the psychological and strategic dynamics of collaborative exploitation, informing policies to combat modern slavery.

€ 1.497.749
ERC STG

Elucidating the phenotypic convergence of proliferation reduction under growth-induced pressure

The UnderPressure project aims to investigate how mechanical constraints from 3D crowding affect cell proliferation and signaling in various organisms, with potential applications in reducing cancer chemoresistance.

€ 1.498.280
ERC STG

Uncovering the mechanisms of action of an antiviral bacterium

This project aims to uncover the mechanisms behind Wolbachia's antiviral protection in insects and develop tools for studying symbiont gene function.

€ 1.500.000
ERC STG

The Ethics of Loneliness and Sociability

This project aims to develop a normative theory of loneliness by analyzing ethical responsibilities of individuals and societies to prevent and alleviate loneliness, establishing a new philosophical sub-field.

€ 1.025.860

Vergelijkbare projecten uit andere regelingen

ERC STG

Elucidating and targeting the mechanisms encoded in the genome of long-lived individuals to improve healthy ageing

This project aims to identify and validate rare genetic variants linked to longevity using CRISPR/Cas9 and high-throughput screening to promote healthy aging and extend lifespan.

€ 1.500.000
ERC COG

Letting up senescence and inflammaging through T cells

LetTBe aims to investigate T cell metabolism and its role in aging to develop strategies that prevent immunosenescence and promote healthy aging.

€ 1.999.944
ERC ADG

Reversing T cell dysfunction in cancer by multimodal genetic screening

This project aims to validate and characterize genes reversing T cell dysfunction in vivo to enhance immunotherapy effectiveness against cancer.

€ 2.499.375
ERC STG

In vivo metabolic determinants of T cell aging trajectories

This project aims to uncover how aging microenvironments affect T cell immunity and explore methods to rejuvenate T cells to combat age-related diseases.

€ 1.500.000